Sundar Jagannath, M.D. Director of the Multiple Myeloma Program and Professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute Discusses Where Elotuzumab Fits In The Overall Management Strategy At The 60th ASH Annual Meeting on Dec 1, 2018.
Where Elotuzumab Fits In The Overall Management Strategy
